It was reported Friday that Apple has tested an app designed to help individuals with prediabetes manage their diet and make healthier lifestyle choices.
They are potentially positioning the company as a competitor to established glucose monitoring firms like Abbott and DexCom.
Earlier this year, Apple conducted a trial with several employees diagnosed with prediabetes.
Sources familiar with the initiative suggest that this project aligns with Apple’s broader efforts to incorporate blood sugar-related features into its health offerings.
Although the tech giant reportedly has no immediate plans to release the app, it may integrate this technology into future health products.
Apple has also been working for over a decade on a noninvasive glucose monitor, which could significantly impact diabetes management.
In 2022, shares of DexCom and Abbott came under pressure as Apple’s advancements in developing a continuous glucose monitoring (CGM) device signaled increased competition within the health-tech industry.
